IL-32媒介のカスパース-43誘導: マクロファージの分化と免疫調節の形成

Guang Wang¹, Wen-Ying Wang², Chao Luo¹

¹Department of Neurosurgery, Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, China.

The Indian journal of medical research

|August 29, 2025

まとめ

インタールイウキン-32 (IL-32) は,マクロファージの分化とM2の偏化を誘導し,免疫回避を促進する. このサイトカインは,脳腫瘍の免疫療法における潜在的な治療標的である.

科学分野:

免疫学
腫瘍学
分子生物学

背景:

グリオブラストーマ・マルチフォーム (GBM) は,非常に免疫抑制性の高い腫瘍微環境 (TME) を有する攻撃的な脳腫瘍である.
炎症を誘発するサイトカインであるインタールイキン-32 (IL-32) の GBM のTMEにおける役割とその免疫細胞への影響は不明である.

研究の目的:

GBMにおけるIL-32の免疫調節機能を調査する.
GBM TME内の単細胞の分化とマクロファージの偏化に対するIL-32の影響を決定する.

主な方法:

トランスクリプトミックのデータ (TCGA-GBM,GEO-GSE156902) と単細胞RNA配列の分析
機能的濃縮分析 (GO,KEGG) とタンパク質相互作用 (PPI) ネットワーク構築
qPCRとウエスタンブロットを用いたIL-32発現の検証;RNA改変遺伝子との相関性の分析.

主要な成果:

IL-32は,GBM組織,特にマイクログリア細胞において,著しく上位調節される.
IL-32は,カスパース-43を介して単細胞の分化を促進し,NF-κBの活性化によってM2の偏化を引き起こす.
IL-32は免疫調節におけるハブ遺伝子として作用し,RNA改変遺伝子METTL3およびTET2との相関を示している.

結論:

IL-32は,M2マクロファージの極化と免疫回避を促進することによって,GBMの免疫抑制性TMEにおいて重要な役割を果たします.
IL-32は,抗GBM免疫反応を強化し,新しい免疫療法を開発するための潜在的な治療目標です.

キーワード:

カスパース-43 GBM IL32 について NF-κB について

さらに関連する動画

08:41

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages

Published on: April 6, 2022

2.8K

06:12

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

2.3K

関連する概念動画

02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

関連する実験動画